DiA Imaging Analysis, a provider of AI-based solutions for ultrasound analysis, closed a $14 million in additional investment led by a consortium of new and existing international investors.
In the latest funding round, new investors include XTX Ventures, Downing Ventures, Philips, Alchimia Ventures, and ICON Community Fund. Existing investors participating in the round include CE Ventures, Connecticut Innovations, Defta Partners, Mindset Ventures, and Dr. Shmuel Cabilly.
The company plans to use the additional capital to expand its portfolio of FDA-cleared and CE-marked AI-based ultrasound analysis solutions that enable clinicians to analyze ultrasound images and identify clinical abnormalities automatically.
With news funds, the company also plans to pursue new and expanded partnerships with ultrasound vendors, PACS, healthcare IT companies, resellers, and distributors and expand its global presence in Asia, Europe, and the U.S.
According to DiA, its AI-based technology imitates how the human eye detects borders and identifies motion, allowing clinicians to capture the right ultrasound images and automatically identify clinical abnormalities that are otherwise difficult to find visually. The company said its cross-platform solution, LVivo Toolbox, currently serves thousands of end-users in more than 20 countries, deployed on ultrasound devices and healthcare IT systems.
Including the latest funding round, DiA has raised a total of $25 million in funding to date; the company has secured channel and commercial partnerships with several healthcare technology providers and distributors, including IBM Watson, Philips, GE Healthcare, and Konica Minolta, among others.
“DiA continues to advance how ultrasound images are captured and analyzed, arming ultrasound users with the ability to make more accurate clinical assessments and ultimately provide better care to patients,” said Hila Goldman Aslan, DiA’s CEO and Co-Founder.
Hila Goldman Aslan added: “We are excited to see the enthusiasm from our growing investor base who see the potential for DiA’s commercial success. We are ready and eager to take DiA to next level by delivering our current and upcoming AI-powered ultrasound solutions to medical settings around the world.”
Healthcare Data Analytics companies secured $1.5 billion in venture capital funding from 33 funding rounds in the first half (1H) of 2021, according to the recently released Mercom Digital Health Funding and M&A Report.